Simulations Plus Inc (SLP) Aligns with EPS Projections and Maintains Full-Year Guidance

Strong Revenue Growth and Dividend Declaration in Q2 Fiscal 2024

Related Keywords

Shawn Oconnor ,Simulations Plus Inc ,Financial Health ,Clinical Pharmacology ,Simulations Plu ,Simulations Plus ,Growth Trajectory ,Revenue Growth ,Arnings Per Share ,